266 related articles for article (PubMed ID: 19280541)
1. Impact of pantoprazole on duodeno-gastro-esophageal reflux (DGER).
Kunsch S; Neesse A; Linhart T; Steinkamp M; Fensterer H; Adler G; Gress TM; Ellenrieder V
Z Gastroenterol; 2009 Mar; 47(3):277-82. PubMed ID: 19280541
[TBL] [Abstract][Full Text] [Related]
2. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
Tack J; Koek G; Demedts I; Sifrim D; Janssens J
Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
[TBL] [Abstract][Full Text] [Related]
3. Increased Duodeno-Gastro-Esophageal Reflux (DGER) in symptomatic GERD patients with a history of cholecystectomy.
Kunsch S; Neesse A; Huth J; Steinkamp M; Klaus J; Adler G; Gress TM; Ellenrieder V
Z Gastroenterol; 2009 Aug; 47(8):744-8. PubMed ID: 19662586
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of duodenogastroesophageal reflux in gastroesophageal reflux disease patients refractory to proton pump inhibitor therapy.
Kunsch S; Neesse A; Linhart T; Nell C; Gress TM; Ellenrieder V
Digestion; 2012; 86(4):315-22. PubMed ID: 23128301
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence of a pathological DGER (duodeno-gastric-oesophageal reflux) in patients with clinical symptoms of reflux disease].
Kunsch S; Linhart T; Fensterer H; Adler G; Gress TM; Ellenrieder V
Z Gastroenterol; 2008 May; 46(5):409-14. PubMed ID: 18428099
[TBL] [Abstract][Full Text] [Related]
7. Duodenogastroesophageal reflux: results of medical treatment and antireflux surgery.
Elhak NG; Mostafa M; Salah T; Haleem M
Hepatogastroenterology; 2008; 55(81):120-6. PubMed ID: 18507090
[TBL] [Abstract][Full Text] [Related]
8. [Is duodeno-gastro-esophageal reflux just a bystander of acid reflux?].
Fein M; Fuchs KH; Freys SM; Maroske J; Tigges H; Thiede A
Zentralbl Chir; 2002 Dec; 127(12):1068-72. PubMed ID: 12529822
[TBL] [Abstract][Full Text] [Related]
9. Duodenogastro-esophageal reflux in children with refractory gastro-esophageal reflux disease.
Hoffman I; Tertychnyy A; Ectors N; De Greef T; Haesendonck N; Tack J
J Pediatr; 2007 Sep; 151(3):307-11. PubMed ID: 17719945
[TBL] [Abstract][Full Text] [Related]
10. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus.
Hak NG; Mostafa M; Salah T; El-Hemaly M; Haleem M; Abd El-Raouf A; Hamdy E
Hepatogastroenterology; 2008; 55(82-83):442-7. PubMed ID: 18613384
[TBL] [Abstract][Full Text] [Related]
11. Importance of duodeno-gastro-esophageal reflux in the medical outpatient practice.
Vaezi MF; Richter JE
Hepatogastroenterology; 1999; 46(25):40-7. PubMed ID: 10228763
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
[TBL] [Abstract][Full Text] [Related]
13. Bile and acid reflux in long and short segment Barrett's esophagus, and in reflux disease.
Pfaffenbach B; Hullerum J; Orth KH; Langer M; Stabenow-Lohbauer U; Lux G
Z Gastroenterol; 2000 Jul; 38(7):565-70. PubMed ID: 10965553
[TBL] [Abstract][Full Text] [Related]
14. Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients.
Calabrese C; Liguori G; Gabusi V; Gionchetti P; Rizzello F; Straforini G; Brugnera R; Di Febo G
Aliment Pharmacol Ther; 2008 Jul; 28(2):250-5. PubMed ID: 18485128
[TBL] [Abstract][Full Text] [Related]
15. Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease.
Peng S; Xiong LS; Xiao YL; Wang AJ; Lin JK; Hu PJ; Chen MH
Chin Med J (Engl); 2010 Aug; 123(15):2012-7. PubMed ID: 20819534
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and clinical relevance of proximal esophageal pH monitoring.
Cool M; Poelmans J; Feenstra L; Tack J
Am J Gastroenterol; 2004 Dec; 99(12):2317-23. PubMed ID: 15571576
[TBL] [Abstract][Full Text] [Related]
17. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
Haag S; Holtmann G
Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
[TBL] [Abstract][Full Text] [Related]
18. Biliary reflux and non-acid reflux are two distinct phenomena: a comparison between 24-hour multichannel intraesophageal impedance and bilirubin monitoring.
Pace F; Sangaletti O; Pallotta S; Molteni P; Porro GB
Scand J Gastroenterol; 2007 Sep; 42(9):1031-9. PubMed ID: 17710667
[TBL] [Abstract][Full Text] [Related]
19. Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain.
Ko SY; Kim SI; Kim JH; Lee JH; Lee KJ; Hong SN; Lee SY; Sung IK; Park HS; Shim CS
J Gastroenterol Hepatol; 2012 Sep; 27(9):1484-9. PubMed ID: 22554344
[TBL] [Abstract][Full Text] [Related]
20. Randomised clinical trial: daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms.
Moraes-Filho JP; Pedroso M; Quigley EM;
Aliment Pharmacol Ther; 2014 Jan; 39(1):47-56. PubMed ID: 24299323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
